論題. 雑誌名. 発行年. 巻. 始頁-終頁
MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug
Resistance: a Prospective Study. J Clin Microbiol 2023; 61:e0162622.
Real-world impact of antifibrotics on prognosis in patients with progressive
fibrosing interstitial lung disease. RMD Open 2023; 9:e002667.

著者
Fukushima K, Matsumoto Y, Matsuki T, Saito H, Motooka D, Komukai S, Fukui E,Yamuchi J, Nitta T, Niitsu T, Abe Y, Nabeshima H, Nagahama Y, Nii T, Tsujino K,Miki K, Kitada S, Kumanogoh A, Akira S, Nakamura S, Kida H
Niitsu T, Fukushima K, Komukai S, Takata S, Abe Y, Nii T, Kuge T, Iwakoshi S,Shiroyama T, Miyake K, Tsujino K, Tanizaki S, Iwahori K, Hirata H, Miki K,Yanagawa M, Takeuchi N, Takeda Y, Kida H, Kumanogoh A

Kawasaki T, Takeda Y, Edahiro R, Shirai Y, Nogami-Itoh M, Matsuki T, Kida H,
Next-generation proteomics of serum extracellular vesicles combined with singleEnomoto T, Hara R, Noda Y, Adachi Y, Niitsu T, Amiya S, Yamaguchi Y, Murakamicell RNA sequencing identifies MACROH2A1 associated with refractory COVIDT, Kato Y, Morita T, Yoshimura H, Yamamoto M, Nakatsubo D, Miyake K,
19. Inflamm Regen 2022; 42:53.
Shiroyama T, Hirata H, Adachi J, Okada Y, Kumanogoh A

Nationwide survey of refractory asthma with bronchiectasis by inflammatory
subtypes. Respir Res 2022; 23:365.

Nomura N, Matsumoto H, Yokoyama A, Nishimura Y, Asano K, Niimi A, Tohda Y,Harada N, Nagase H, Nagata M, Inoue H, Kondo M, Horiguchi T, Miyahara N,Hizawa N, Hojo M, Hattori N, Hashimoto N, Yamasaki A, Kadowaki T, Kimura T,Miki M, Taniguchi H, Toyoshima M, Kawamura T, Matsuno O, Sato Y, Sunadome
H, Nagasaki T, Oguma T, Hirai T; BEXAS study.

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy foradvanced non-small cell lung cancer patients. Sci Rep 2022; 12:17461.

Iwahori K, Uenami T, Yano Y, Ueda T, Tone M, Naito Y, Suga Y, Fukushima K,Shiroyama T, Miyake K, Koyama S, Hirata H, Nagatomo I, Kida H, Mori M, Takeda
Y, Kumanogoh A, Wada H.

CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response
Otsuka T, Nishida S, Shibahara T, Temizoz B, Hamaguchi M, Shiroyama T, Kimuraand enhances cytotoxic activity in advanced lung cancer patients: a phase I study. K, Miyake K, Hirata H, Mizuno Y, Yagita M, Manabe Y, Kuroda E, Takeda Y, Kida
BMC Cancer 2022; 22:744.
H, Ishii KJ, Kumanogoh A.
Kuge T, Fukushima K, Matsumoto Y, Saito H, Abe Y, Akiba E, Haduki K, Nitta T,
Chronic Pulmonary Disease Caused by Tsukamurella toyonakaense. Emerg InfectKawano A, Tanaka M, Hattori Y, Kawasaki T, Matsuki T, Shiroyama T, Motooka D,Dis 2022; 28:1437-1441.
Tsujino K, Miki K, Mori M, Kitada S, Nakamura S, Iida T, Kumanogoh A, Kida H.
Longitudinal alterations of the gut mycobiota and microbiota on COVID-19
severity. BMC Infect Dis 2022; 22:572.

Maeda Y, Motooka D, Kawasaki T, Oki H, Noda Y, Adachi Y, Niitsu T, Okamoto S,Tanaka K, Fukushima K, Amiya S, Hara R, Oguro-Igashira E, Matsuki T, Hirata H,Takeda Y, Kida H, Kumanogoh A, Nakamura S, Takeda K.

Genomic repertoires linked with pathogenic potency of arthritogenic Prevotellacopri isolated from the gut of patients with rheumatoid arthritis. Ann Rheum Dis
2023; 82:621-629.

Nii T, Maeda Y, Motooka D, Naito M, Matsumoto Y, Ogawa T, Oguro-Igashira E,
Kishikawa T, Yamashita M, Koizumi S, Kurakawa T, Okumura R, Kayama H,Murakami M, Sakaguchi T, Das B, Nakamura S, Okada Y, Kumanogoh A, Takeda
K.

Shirai Y, Nakanishi Y, Suzuki A, Konaka H, Nishikawa R, Sonehara K, Namba S,Multi-trait and cross-population genome-wide association studies across
Tanaka H, Masuda T, Yaga M, Satoh S, Izumi M, Mizuno Y, Jo T, Maeda Y, Nii T,
autoimmune and allergic diseases identify shared and distinct genetic component.
Oguro-Igashira E; Biobank Japan Project; Morisaki T, Kamatani Y, Nakayamada
Ann Rheum Dis 2022; 81:1301-1312.
S, Nishigori C, Tanaka Y, Takeda Y, Yamamoto K, Kumanogoh A, Okada Y.
Nishioka Y, Toyoda Y, Egashira R, Johkoh T, Terasaki Y, Hebisawa A, Abe K,Nationwide retrospective observational study of idiopathic dendriform pulmonary Baba T, Fujikura Y, Fujita E, Hamada N, Handa T, Hasegawa Y, Hidaka K, Hisada
ossification: clinical features with a progressive phenotype. BMJ Open Respir Res T, Hisata S, Honjo C, Ichikado K, Inoue Y, Izumi S, Kato M, Kishimoto T, Okamoto
2022; 9:e001337.
M, Miki K, Mineshita M, Nakamura Y, Sakamoto S, Sano M, Tsukada Y, Yamasue
M, Bando Y, Homma S, Hagiwara K, Suda T, Inase N.
Futami Y, Takeda Y, Koba T, Narumi R, Nojima Y, Ito M, Nakayama M, Ishida M,
Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers
Yoshimura H, Naito Y, Fukushima K, Takimoto T, Edahiro R, Matsuki T, Nojima S,
for sarcoidosis using proteomics of serum extracellular vesicles. Int Immunol 2022;
Hirata H, Koyama S, Iwahori K, Nagatomo I, Shirai Y, Suga Y, Satoh S, Futami S,
34:327-340
Miyake K, Shiroyama T, Inoue Y, Adachi J, Tomonaga T, Ueda K, Kumanogoh A.

Nationwide survey of refractory asthma with bronchiectasis by inflammatory
subtypes. Respir Res 2022; 23:365.

肺非結核性抗酸菌症の診断基準. 結核 2022.12
非結核性抗酸菌症の診断〜血清診断も含めて〜. 呼吸器ジャーナル 2022; 70(2) 特集「どう診る? 急増する非結核性抗酸菌症、見逃せない結核」
肺胞蛋白症. 今日の治療指針 2023.1.1医学書院(東京)
肺胞蛋白症診療ガイドライン 2022.6.15 日本呼吸器学会
メディカル・トピックス 関節リウマチに伴う肺疾患について. 豊中医師会月報 2023.3

Nomura N, Matsumoto H, Yokoyama A, Nishimura Y, Asano K, Niimi A, Tohda Y,Harada N, Nagase H, Nagata M, Inoue H, Kondo M, Horiguchi T, Miyahara N,Hizawa N, Hojo M, Hattori N, Hashimoto N, Yamasaki A, Kadowaki T, Kimura T,Miki M, Taniguchi H, Toyoshima M, Kawamura T, Matsuno O, Sato Y, Sunadome
H, Nagasaki T, Oguma T, Hirai T; BEXAS study.
木田博, 北田清悟, 福島清春, 安部祐子, 前倉亮治.
福島清春, 木田博
木田博
木田博 (分担)新居卓朗